{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T02:55:28Z","timestamp":1785207328143,"version":"3.55.0"},"reference-count":145,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2025,5,29]],"date-time":"2025-05-29T00:00:00Z","timestamp":1748476800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Metabolites"],"abstract":"<jats:p>Background: Lysosomal storage disorders (LSDs) are rare inherited metabolic diseases characterized by defects in lysosomal enzyme function or membrane transport. These defects lead to substrate accumulation and multisystemic manifestations. This review focuses on gastrointestinal (GI) involvement in LSDs, which is a significant but often overlooked aspect of these disorders. Methods: A comprehensive literature review was conducted to examine the pathophysiology, clinical presentation, diagnosis and management of GI manifestations in several LSDs, including Fabry disease, Gaucher disease, Pompe disease, Niemann\u2013Pick disease type C, mucopolysaccharidoses and Wolman disease. Results: The pathogenesis of GI involvement in LSDs varies and encompasses substrate accumulation in enterocytes, mesenteric lymphadenopathy, mass effects, smooth muscle dysfunction, vasculopathy, neuropathy, inflammation and alterations to the microbiota. Clinical presentations range from non-specific symptoms, such as abdominal pain, diarrhea and malabsorption, to more severe complications, such as protein-losing enteropathy and inflammatory bowel disease. Diagnosis often requires a high level of suspicion, as GI symptoms may precede the diagnosis of the underlying LSD or be misattributed to more common conditions. Management strategies include disease-specific treatments, such as enzyme replacement therapy or substrate reduction therapy, as well as supportive care and targeted interventions for specific GI complications. Conclusions: This review highlights the importance of recognizing and properly managing GI manifestations in LSDs to improve patient outcomes and quality of life. It also emphasizes the need for further research to develop more effective treatments for life-threatening GI complications associated with these rare genetic disorders.<\/jats:p>","DOI":"10.3390\/metabo15060361","type":"journal-article","created":{"date-parts":[[2025,5,29]],"date-time":"2025-05-29T06:25:04Z","timestamp":1748499904000},"page":"361","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["The Hidden Burden: Gastrointestinal Involvement in Lysosomal Storage Disorders"],"prefix":"10.3390","volume":"15","author":[{"given":"Vincenza","family":"Gragnaniello","sequence":"first","affiliation":[{"name":"Division of Inherited Metabolic Diseases, Department of Women\u2019s and Children\u2019s Health, University Hospital of Padova, 35128 Padova, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Cazzorla","sequence":"additional","affiliation":[{"name":"Division of Inherited Metabolic Diseases, Department of Women\u2019s and Children\u2019s Health, University Hospital of Padova, 35128 Padova, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Gueraldi","sequence":"additional","affiliation":[{"name":"Division of Inherited Metabolic Diseases, Department of Women\u2019s and Children\u2019s Health, University Hospital of Padova, 35128 Padova, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Puma","sequence":"additional","affiliation":[{"name":"Division of Inherited Metabolic Diseases, Department of Women\u2019s and Children\u2019s Health, University Hospital of Padova, 35128 Padova, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Loro","sequence":"additional","affiliation":[{"name":"Division of Inherited Metabolic Diseases, Department of Women\u2019s and Children\u2019s Health, University Hospital of Padova, 35128 Padova, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7724-137X","authenticated-orcid":false,"given":"Alberto B.","family":"Burlina","sequence":"additional","affiliation":[{"name":"Division of Inherited Metabolic Diseases, Department of Women\u2019s and Children\u2019s Health, University Hospital of Padova, 35128 Padova, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,5,29]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/s41572-018-0025-4","article-title":"Lysosomal Storage Diseases","volume":"4","author":"Platt","year":"2018","journal-title":"Nat. Rev. Dis. Primers"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1097\/WCO.0b013e32834a9433","article-title":"Fabry Disease","volume":"24","author":"Toyooka","year":"2011","journal-title":"Curr. Opin. Neurol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/1750-1172-5-30","article-title":"Fabry Disease","volume":"5","author":"Germain","year":"2010","journal-title":"Orphanet J. Rare Dis."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Gragnaniello, V., Burlina, A.P., Polo, G., Giuliani, A., Salviati, L., Duro, G., Cazzorla, C., Rubert, L., Maines, E., and Germain, D.P. (2021). Newborn Screening for Fabry Disease in Northeastern Italy: Results of Five Years of Experience. Biomolecules, 11.","DOI":"10.3390\/biom11070951"},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Gragnaniello, V., Burlina, A.P., Commone, A., Gueraldi, D., Puma, A., Porc\u00f9, E., Stornaiuolo, M., Cazzorla, C., and Burlina, A.B. (2023). Newborn Screening for Fabry Disease: Current Status of Knowledge. Int. J. Neonatal Screen., 9.","DOI":"10.3390\/ijns9020031"},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Gragnaniello, V., Cazzorla, C., Gueraldi, D., Puma, A., Loro, C., Porc\u00f9, E., Stornaiuolo, M., Miglioranza, P., Salviati, L., and Burlina, A.P. (2023). Light and Shadows in Newborn Screening for Lysosomal Storage Disorders: Eight Years of Experience in Northeast Italy. Int. J. Neonatal Screen., 10.","DOI":"10.20944\/preprints202311.0727.v1"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/cge.12673","article-title":"Gastrointestinal Involvement in Fabry Disease. So Important, yet Often Neglected","volume":"89","author":"Politei","year":"2016","journal-title":"Clin. Genet."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/8904_2017_28","article-title":"Improvement of Fabry Disease-Related Gastrointestinal Symptoms in a Significant Proportion of Female Patients Treated with Agalsidase Beta: Data from the Fabry Registry","volume":"Volume 38","author":"Morava","year":"2017","journal-title":"JIMD Reports, Volume 38"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1136\/jmg.2008.065904","article-title":"Natural Course of Fabry Disease: Changing Pattern of Causes of Death in FOS\u2014Fabry Outcome Survey","volume":"46","author":"Mehta","year":"2009","journal-title":"J. Med. Genet."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1007\/s00431-003-1299-3","article-title":"The Early Clinical Phenotype of Fabry Disease: A Study on 35 European Children and Adolescents","volume":"162","author":"Ries","year":"2003","journal-title":"Eur. J. Pediatr."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1203\/PDR.0b013e318183f132","article-title":"Characterization of Fabry disease in 352 pediatric patients in the Fabry Registry","volume":"64","author":"Hopkin","year":"2008","journal-title":"Pediatr. Res."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1038\/gim.2014.120","article-title":"Fabry Disease in Infancy and Early Childhood: A Systematic Literature Review","volume":"17","author":"Laney","year":"2015","journal-title":"Genet. Med."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.dld.2018.02.011","article-title":"Non-Specific Gastrointestinal Features: Could It Be Fabry Disease?","volume":"50","author":"Hilz","year":"2018","journal-title":"Dig. Liver Dis."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"110664","DOI":"10.1016\/j.nut.2019.110664","article-title":"Could Nutritional Therapy Take Us Further in Our Approaches to Fabry Disease?","volume":"72","author":"Ravarotto","year":"2020","journal-title":"Nutrition"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1177\/1756283X16642936","article-title":"Understanding the Gastrointestinal Manifestations of Fabry Disease: Promoting Prompt Diagnosis","volume":"9","author":"Karaa","year":"2016","journal-title":"Ther. Adv. Gastroenterol."},{"key":"ref_16","first-page":"368","article-title":"Fabry disease\u2014What a gastroenterologist should know","volume":"18","author":"Hryszko","year":"2023","journal-title":"Prz. Gastroenterol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1097\/AJP.0b013e318074c986","article-title":"Nature and Prevalence of Pain in Fabry Disease and Its Response to Enzyme Replacement Therapy\u2014A Retrospective Analysis From the Fabry Outcome Survey","volume":"23","author":"Hoffmann","year":"2007","journal-title":"Clin. J. Pain."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"e00633","DOI":"10.14309\/ctg.0000000000000633","article-title":"Gastrointestinal Sensory Neuropathy and Dysmotility in Fabry Disease: Presentations and Effect on Patient\u2019s Quality of Life","volume":"14","author":"Bar","year":"2023","journal-title":"Clin. Transl. Gastroenterol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1080\/08035320600618825","article-title":"The Mainz Severity Score Index (MSSI): Development and validation of a system for scoring the signs and symptoms of Fabry disease","volume":"95","author":"Beck","year":"2006","journal-title":"Acta Paediatr. Suppl."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"2983","DOI":"10.1007\/s11136-021-02847-9","article-title":"FABry Disease Patient-Reported Outcome-GastroIntestinal (FABPRO-GI): A New Fabry Disease-Specific Gastrointestinal Outcomes Instrument","volume":"30","author":"Shields","year":"2021","journal-title":"Qual. Life Res."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1186\/s13023-020-01436-2","article-title":"Pathologic Substrate of Gastropathy in Anderson-Fabry Disease","volume":"15","author":"Narula","year":"2020","journal-title":"Orphanet J. Rare Dis."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1016\/j.jpeds.2010.02.012","article-title":"Misdiagnosis in Fabry Disease","volume":"156","author":"Marchesoni","year":"2010","journal-title":"J. Pediatr."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"2027852","DOI":"10.1080\/19490976.2022.2027852","article-title":"Fabry Disease\u2014A Multisystemic Disease with Gastrointestinal Manifestations","volume":"14","author":"Lenders","year":"2022","journal-title":"Gut Microbes"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1007\/s40265-021-01486-1","article-title":"Fabry Disease: The Current Treatment Landscape","volume":"81","author":"Lenders","year":"2021","journal-title":"Drugs"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/j.1651-2227.2002.tb03113.x","article-title":"Arterial Remodelling in Fabry Disease","volume":"91","author":"Boutouyrie","year":"2002","journal-title":"Acta Paediatr."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1111\/j.1523-1755.2005.00294.x","article-title":"Anemia Is a New Complication in Fabry Disease: Data from the Fabry Outcome Survey","volume":"67","author":"Kleinert","year":"2005","journal-title":"Kidney Int."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"227","DOI":"10.2217\/fmb-2019-0249","article-title":"Unraveling the Drivers and Consequences of Gut Microbiota Disruption in Fabry Disease: The Lyso-Gb3 Link","volume":"15","author":"Politei","year":"2020","journal-title":"Future Microbiol."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Aguilera-Correa, J.-J., Madrazo-Clemente, P., Mart\u00ednez-Cuesta, M.D.C., Pel\u00e1ez, C., Ortiz, A., S\u00e1nchez-Ni\u00f1o, M.D., Esteban, J., and Requena, T. (2019). Lyso-Gb3 Modulates the Gut Microbiota and Decreases Butyrate Production. Sci. Rep., 9.","DOI":"10.1038\/s41598-019-48426-4"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1038\/ki.2012.345","article-title":"Chronic Kidney Disease Alters Intestinal Microbial Flora","volume":"83","author":"Vaziri","year":"2013","journal-title":"Kidney Int."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1080\/0886022X.2020.1864404","article-title":"Specific Alterations in Gut Microbiota in Patients with Chronic Kidney Disease: An Updated Systematic Review","volume":"43","author":"Zhao","year":"2021","journal-title":"Ren. Fail."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"2256045","DOI":"10.1080\/19490976.2023.2256045","article-title":"Disruption of the microbiota-gut-brain axis is a defining characteristic of the \u03b1-Gal A (-\/0) mouse model of Fabry disease","volume":"15","author":"Delprete","year":"2023","journal-title":"Gut Microbes"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.ymgme.2022.10.005","article-title":"Clinical Relevance of Globotriaosylceramide Accumulation in Fabry Disease and the Effect of Agalsidase Beta in Affected Tissues","volume":"137","author":"Thurberg","year":"2022","journal-title":"Mol. Genet. Metab."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s13023-015-0253-6","article-title":"Recommendations for Initiation and Cessation of Enzyme Replacement Therapy in Patients with Fabry Disease: The European Fabry Working Group Consensus Document","volume":"10","author":"Biegstraaten","year":"2015","journal-title":"Orphanet J. Rare Dis."},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Frustaci, A., Najafian, B., Donato, G., Verardo, R., Chimenti, C., Sansone, L., Belli, M., Vernucci, E., and Russo, M.A. (2022). Divergent Impact of Enzyme Replacement Therapy on Human Cardiomyocytes and Enterocytes Affected by Fabry Disease: Correlation with Mannose-6-Phosphate Receptor Expression. J. Clin. Med., 11.","DOI":"10.3390\/jcm11051344"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/s13023-018-0813-7","article-title":"Migalastat Improves Diarrhea in Patients with Fabry Disease: Clinical-Biomarker Correlations from the Phase 3 FACETS Trial","volume":"13","author":"Schiffmann","year":"2018","journal-title":"Orphanet J. Rare Dis."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1038\/s41436-019-0451-z","article-title":"Efficacy of the pharmacologic chaperone migalastat in a subset of male patients with the classic phenotype of Fabry disease and migalastat-amenable variants: Data from the phase 3 randomized, multicenter, double-blind clinical trial and extension study","volume":"21","author":"Germain","year":"2019","journal-title":"Genet. Med."},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Bellini, M., Tonarelli, S., Nagy, A., Pancetti, A., Costa, F., Ricchiuti, A., De Bortoli, N., Mosca, M., Marchi, S., and Rossi, A. (2020). Low FODMAP Diet: Evidence, Doubts, and Hopes. Nutrients, 12.","DOI":"10.3390\/nu12010148"},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Gugelmo, G., Vitturi, N., Francini-Pesenti, F., Fasan, I., Lenzini, L., Valentini, R., Carraro, G., Avogaro, A., and Spinella, P. (2023). Gastrointestinal Manifestations and Low-FODMAP Protocol in a Cohort of Fabry Disease Adult Patients. Nutrients, 15.","DOI":"10.3390\/nu15030658"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1053\/j.gastro.2020.06.007","article-title":"Effects of Orally Delivered Alpha-Galactosidase A on Gastrointestinal Symptoms in Patients With Fabry Disease","volume":"159","author":"Lenders","year":"2020","journal-title":"Gastroenterology"},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Stirnemann, J., Belmatoug, N., Camou, F., Serratrice, C., Froissart, R., Caillaud, C., Levade, T., Astudillo, L., Serratrice, J., and Brassier, A. (2017). A Review of Gaucher Disease Pathophysiology, Clinical Presentation and Treatments. Int. J. Mol. Sci., 18.","DOI":"10.3390\/ijms18020441"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1002\/ajh.24957","article-title":"Demographics and Patient Characteristics of 1209 Patients with Gaucher Disease: Descriptive Analysis from the Gaucher Outcome Survey (GOS)","volume":"93","author":"Zimran","year":"2018","journal-title":"Am. J. Hematol."},{"key":"ref_42","first-page":"414","article-title":"Bone Disease in Early Detected Gaucher Type I Disease: A Case Report","volume":"63","author":"Gragnaniello","year":"2022","journal-title":"JIMD Rep."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1002\/ajmg.a.63196","article-title":"Long-Term Follow-up of a Patient with Neonatal Form of Gaucher Disease","volume":"191","author":"Gragnaniello","year":"2023","journal-title":"Am. J. Med. Genet. A"},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"M\u00e9ndez-Cobi\u00e1n, D.A., Guzm\u00e1n-Silahua, S., Garc\u00eda-Hern\u00e1ndez, D., Conde-S\u00e1nchez, J., Casta\u00f1eda-Borrayo, Y., Duey, K.L., Zavala-Cerna, M.G., Rubio-Jurado, B., and Nava-Zavala, A.H. (2024). An Overview of Gaucher Disease. Diagnostics, 14.","DOI":"10.3390\/diagnostics14242840"},{"key":"ref_45","first-page":"100473","article-title":"Very Rare Condition of Multiple Gaucheroma: A Case Report and Review of the Literature","volume":"20","author":"Tseng","year":"2019","journal-title":"Mol. Genet. Metab. Rep."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1080\/08880018.2021.1989098","article-title":"Abdominal Lymphadenopathy in Children with Gaucher Disease: Relation to Disease Severity and Glucosylsphingosine","volume":"39","author":"Tantawy","year":"2022","journal-title":"Pediatr. Hematol. Oncol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1007\/s00247-002-0761-0","article-title":"Mesenteric Mass in a Young Girl\u2014An Unusual Site for Gaucher\u2019s Disease","volume":"32","author":"Lim","year":"2002","journal-title":"Pediatr. Radiol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"708","DOI":"10.24953\/turkjped.2021.04.020","article-title":"A Very Rare Cause of Protein Losing Enteropathy: Gaucher Disease","volume":"63","author":"Demir","year":"2021","journal-title":"Turk. J. Pediatr."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.jpeds.2006.10.062","article-title":"Gaucher Disease: Progressive Mesenteric and Mediastinal Lymphadenopathy Despite Enzyme Therapy","volume":"150","author":"Burrow","year":"2007","journal-title":"J. Pediatr."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.ymgme.2011.12.010","article-title":"Progressive Mesenteric Lymphadenopathy with Protein-Losing Enteropathy; a Devastating Complication in Gaucher Disease","volume":"105","author":"Lee","year":"2012","journal-title":"Mol. Genet. Metab."},{"key":"ref_51","first-page":"13","article-title":"Successful Therapy for Protein-Losing Enteropathy Caused by Chronic Neuronopathic Gaucher Disease","volume":"6","author":"Mhanni","year":"2016","journal-title":"Mol. Genet. Metab. Rep."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1177\/2150135119872196","article-title":"Budesonide for Protein Losing Enteropathy in Patients with Fontan Circulation: A Systematic Review and Meta-Analysis","volume":"11","author":"Kewcharoen","year":"2020","journal-title":"World J. Pediatr. Congenit. Heart Surg."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.ymgme.2021.06.009","article-title":"Throwing a Spotlight on Under-Recognized Manifestations of Gaucher Disease: Pulmonary Involvement, Lymphadenopathy and Gaucheroma","volume":"133","author":"Ramaswami","year":"2021","journal-title":"Mol. Genet. Metab."},{"key":"ref_54","first-page":"101075","article-title":"A Case of Gaucher Disease with a Rare Complication of Gaucheroma and Protein-Losing Enteropathy","volume":"39","author":"Zhang","year":"2024","journal-title":"Mol. Genet. Metab. Rep."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"047","DOI":"10.1055\/s-0040-1714699","article-title":"Large Mesenteric Gaucheroma Responds to Substrate Reduction Therapy: A New Management of Gaucheromas","volume":"11","author":"Yano","year":"2022","journal-title":"J. Pediatr. Genet."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.bcmd.2016.10.018","article-title":"Gaucheromas: When Macrophages Promote Tumor Formation and Dissemination","volume":"68","author":"Ivanova","year":"2018","journal-title":"Blood Cells Mol. Dis."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"2502","DOI":"10.4103\/0366-6999.191825","article-title":"Gaucher Disease with Mesenteric Lymphadenopathy: A Case with 13-Year Follow-Up","volume":"129","author":"Ye","year":"2016","journal-title":"Chin. Med. J."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.ymgme.2014.08.011","article-title":"CNS, Lung, and Lymph Node Involvement in Gaucher Disease Type 3 after 11years of Therapy: Clinical, Histopathologic, and Biochemical Findings","volume":"114","author":"Burrow","year":"2015","journal-title":"Mol. Genet. Metab."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1007\/s00431-010-1235-2","article-title":"Clinical Practice. Protein-Losing Enteropathy in Children","volume":"169","author":"Braamskamp","year":"2010","journal-title":"Eur. J. Pediatr."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1002\/mrd.1080350415","article-title":"Developmental expression of the IGF-II\/mannose 6-phosphate receptor","volume":"35","author":"Nissley","year":"1993","journal-title":"Mol. Reprod. Dev."},{"key":"ref_61","doi-asserted-by":"crossref","unstructured":"Kim, Y.-M., Shin, D.H., Park, S.B., Cheon, C.K., and Yoo, H.-W. (2017). Case Report of Unexpected Gastrointestinal Involvement in Type 1 Gaucher Disease: Comparison of Eliglustat Tartrate Treatment and Enzyme Replacement Therapy. BMC Med. Genet., 18.","DOI":"10.1186\/s12881-017-0403-x"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"459","DOI":"10.15403\/jgld.2014.1121.274.bow","article-title":"Small Bowel Mucosal Involvement and Mesenteric Mass Formation in a Young Female with Type 3 Gaucher Disease. A Case Report","volume":"27","author":"Emanuel","year":"2018","journal-title":"J. Gastrointestin. Liver Dis."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"271","DOI":"10.17712\/nsj.2015.3.20140622","article-title":"Gaucher Disease: Unusual Presentation and Mini-Review","volume":"20","author":"Rizk","year":"2015","journal-title":"Neurosciences"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.bcmd.2016.09.002","article-title":"Appendiceal Involvement in a Patient with Gaucher Disease","volume":"68","author":"Kocic","year":"2018","journal-title":"Blood Cells Mol. Dis."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1136\/pgmj.67.787.479","article-title":"Massive Gastrointestinal Haemorrhage Associated with Ileal Lymphoid Hyperplasia in Gaucher\u2019s Disease","volume":"67","author":"Jones","year":"1991","journal-title":"Postgrad. Med. J."},{"key":"ref_66","first-page":"346","article-title":"Gaucher\u2019s disease complicated by bleeding esophageal varices and colonic infiltration by Gaucher cells","volume":"86","author":"Henderson","year":"1991","journal-title":"Am. J. Gastroenterol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1540\/jsmr.54.100","article-title":"The Impact of Pompe Disease on Smooth Muscle: A Review","volume":"54","author":"Mccall","year":"2018","journal-title":"J. Smooth Muscle Res."},{"key":"ref_68","first-page":"100929","article-title":"Newborn Screening for Pompe Disease in Italy: Long-Term Results and Future Challenges","volume":"33","author":"Gragnaniello","year":"2022","journal-title":"Mol. Genet. Metab. Rep."},{"key":"ref_69","doi-asserted-by":"crossref","unstructured":"Gragnaniello, V., Rizzardi, C., Commone, A., Gueraldi, D., Maines, E., Salviati, L., Di Salvo, G., and Burlina, A.B. (2023). Unusual Evolution of Hypertrophic Cardiomyopathy in Non-Compaction Myocardium in a Pompe Disease Patient. J. Clin. Med., 12.","DOI":"10.3390\/jcm12062365"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.jpeds.2005.11.033","article-title":"A Retrospective, Multinational, Multicenter Study on the Natural History of Infantile-Onset Pompe Disease","volume":"148","author":"Kishnani","year":"2006","journal-title":"J. Pediatr."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1186\/s13023-024-03373-w","article-title":"The European Reference Network for Metabolic Diseases (MetabERN) Clinical Pathway Recommendations for Pompe Disease (Acid Maltase Deficiency, Glycogen Storage Disease Type II)","volume":"19","author":"Parenti","year":"2024","journal-title":"Orphanet J. Rare Dis."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1002\/(SICI)1096-9896(199911)189:3<416::AID-PATH445>3.0.CO;2-6","article-title":"Pathological Features of Glycogen Storage Disease Type II Highlighted in the Knockout Mouse Model","volume":"189","author":"Bijvoet","year":"1999","journal-title":"J. Pathol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1002\/mus.10381","article-title":"Morphological Changes in Muscle Tissue of Patients with Infantile Pompe\u2019s Disease Receiving Enzyme Replacement Therapy","volume":"27","author":"Winkel","year":"2003","journal-title":"Muscle Nerve"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.ymgme.2010.01.015","article-title":"Prognostic Factors for the Late Onset Pompe Disease with Enzyme Replacement Therapy: From Our Experience of 4 Cases Including an Autopsy Case","volume":"100","author":"Kobayashi","year":"2010","journal-title":"Mol. Genet. Metab."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.ymgme.2012.05.007","article-title":"Autopsy Findings in Late-Onset Pompe Disease: A Case Report and Systematic Review of the Literature","volume":"106","author":"Proia","year":"2012","journal-title":"Mol. Genet. Metab."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1002\/mus.880100311","article-title":"The pattern of involvement of adult-onset acid maltase deficiency at autopsy","volume":"10","author":"Swash","year":"1987","journal-title":"Muscle Nerve"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1540\/jsmr.57.8","article-title":"Glycogen Accumulation in Smooth Muscle of a Pompe Disease Mouse Model","volume":"57","author":"McCall","year":"2021","journal-title":"J. Smooth Muscle Res."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/8904_2015_426","article-title":"Postmortem Findings and Clinical Correlates in Individuals with Infantile-Onset Pompe Disease","volume":"23","author":"Zschocke","year":"2015","journal-title":"JIMD Reports, Volume 23"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1038\/gim.2012.44","article-title":"The Emerging Phenotype of Long-Term Survivors with Infantile Pompe Disease","volume":"14","author":"Prater","year":"2012","journal-title":"Genet. Med."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s00455-009-9252-x","article-title":"Oropharyngeal Dysphagia in Infants and Children with Infantile Pompe Disease","volume":"25","author":"Jones","year":"2010","journal-title":"Dysphagia"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1007\/s10545-011-9404-7","article-title":"Facial-muscle Weakness, Speech Disorders and Dysphagia Are Common in Patients with Classic Infantile Pompe Disease Treated with Enzyme Therapy","volume":"35","author":"Ebbink","year":"2012","journal-title":"J. Inher. Metab. Dis."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1097\/01.gim.0000218152.87434.f3","article-title":"Pompe Disease Diagnosis and Management Guideline","volume":"8","author":"Kishnani","year":"2006","journal-title":"Genet. Med."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1055\/s-0029-1231066","article-title":"Treatment of Gastroesophageal Reflux with Nissen Fundoplication and Gastrostomy Tube Insertion in Infantile Pompe\u2019s Disease","volume":"40","author":"Hirschburger","year":"2009","journal-title":"Neuropediatrics"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1159\/000338776","article-title":"Incontinence in Late-Onset Pompe Disease: An Underdiagnosed Treatable Condition","volume":"68","author":"Remiche","year":"2012","journal-title":"Eur. Neurol."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/8904_2014_334","article-title":"Urge Incontinence and Gastrointestinal Symptoms in Adult Patients with Pompe Disease: A Cross-Sectional Survey","volume":"Volume 17","author":"Zschocke","year":"2014","journal-title":"JIMD Reports, Volume 17"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.ymgme.2010.06.003","article-title":"Pompe Disease: Dramatic Improvement in Gastrointestinal Function Following Enzyme Replacement Therapy. A Report of Three Later-Onset Patients","volume":"101","author":"Bernstein","year":"2010","journal-title":"Mol. Genet. Metab."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1007\/s00415-010-5618-0","article-title":"Abnormalities of Cerebral Arteries Are Frequent in Patients with Late-Onset Pompe Disease","volume":"257","author":"Sacconi","year":"2010","journal-title":"J. Neurol."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.jns.2015.04.012","article-title":"Gastrointestinal Symptoms in Late-Onset Pompe Disease: Early Response to Enzyme Replacement Therapy","volume":"353","author":"Pardo","year":"2015","journal-title":"J. Neurol. Sci."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1002\/mus.24618","article-title":"Fibromyalgia-like Symptoms Associated with Irritable Bowel Syndrome: A Challenging Diagnosis of Late-onset Pompe Disease","volume":"52","author":"Attarian","year":"2015","journal-title":"Muscle Nerve"},{"key":"ref_90","doi-asserted-by":"crossref","unstructured":"Korlimarla, A., Lim, J.-A., McIntosh, P., Zimmerman, K., Sun, B.D., and Kishnani, P.S. (2021). New Insights into Gastrointestinal Involvement in Late-Onset Pompe Disease: Lessons Learned from Bench and Bedside. J. Clin. Med., 10.","DOI":"10.3390\/jcm10153395"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"619","DOI":"10.3233\/JND-220792","article-title":"Diagnostic Yield of Chilaiditi\u2019s Sign in Advanced-Phase Late-Onset Pompe Disease","volume":"9","author":"Takahashi","year":"2022","journal-title":"J. Neuromuscul. Dis."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.ymgme.2012.11.013","article-title":"Low Anal Sphincter Tone in Infantile-Onset Pompe Disease: An Emerging Clinical Issue in Enzyme Replacement Therapy Patients Requiring Special Attention","volume":"108","author":"Tan","year":"2013","journal-title":"Mol. Genet. Metab."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.ajpath.2015.12.002","article-title":"Hepatic Primary and Secondary Cholesterol Deposition and Damage in Niemann-Pick Disease","volume":"186","author":"Bosch","year":"2016","journal-title":"Am. J. Pathol."},{"key":"ref_94","doi-asserted-by":"crossref","unstructured":"Modin, L., Ng, V., Gissen, P., Raiman, J., Pfister, E.D., Das, A., Santer, R., Faghfoury, H., Santra, S., and Baumann, U. (2021). A Case Series on Genotype and Outcome of Liver Transplantation in Children with Niemann-Pick Disease Type C. Children, 8.","DOI":"10.3390\/children8090819"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1750-1172-5-16","article-title":"Niemann-Pick Disease Type C","volume":"5","author":"Vanier","year":"2010","journal-title":"Orphanet J. Rare Dis."},{"key":"ref_96","doi-asserted-by":"crossref","unstructured":"Kawazoe, T., Yamamoto, T., Narita, A., Ohno, K., Adachi, K., Nanba, E., Noguchi, A., Takahashi, T., Maekawa, M., and Eto, Y. (2018). Phenotypic Variability of Niemann-Pick Disease Type C Including a Case with Clinically Pure Schizophrenia: A Case Report. BMC Neurol., 18.","DOI":"10.1186\/s12883-018-1124-2"},{"key":"ref_97","first-page":"s00451807714","article-title":"Practical recommendations for diagnosis, management, and follow-up of Niemann-Pick type-C disease patients: A Brazilian perspective","volume":"83","author":"Horovitz","year":"2025","journal-title":"Arq. Neuropsiquiatr."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1136\/gutjnl-2015-310382","article-title":"Impaired Antibacterial Autophagy Links Granulomatous Intestinal Inflammation in Niemann\u2013Pick Disease Type C1 and XIAP Deficiency with NOD2 Variants in Crohn\u2019s Disease","volume":"66","author":"Schwerd","year":"2017","journal-title":"Gut"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.braindev.2023.06.006","article-title":"Neonatal Onset of Niemann-Pick Disease Type C in a Patient with Cholesterol Re-Accumulation in the Transplanted Liver and Inflammatory Bowel Disease","volume":"45","author":"Koshu","year":"2023","journal-title":"Brain Dev."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1111\/j.1399-0004.2004.00219.x","article-title":"The Mainz Severity Score Index: A New Instrument for Quantifying the Anderson\u2013Fabry Disease Phenotype, and the Response of Patients to Enzyme Replacement Therapy","volume":"65","author":"Whybra","year":"2004","journal-title":"Clin. Genet."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"e229780","DOI":"10.1136\/bcr-2019-229780","article-title":"Niemann-Pick Disease Type C Presenting as Very Early Onset Inflammatory Bowel Disease","volume":"12","author":"Dike","year":"2019","journal-title":"BMJ Case Rep."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1177\/003693300505000213","article-title":"Niemann-Pick Disease Type C and Crohn\u2019s Disease","volume":"50","author":"Steven","year":"2005","journal-title":"Scott. Med. J."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1038\/s41586-021-03762-2","article-title":"Tonic Prime-Boost of STING Signalling Mediates Niemann\u2013Pick Disease Type C","volume":"596","author":"Chu","year":"2021","journal-title":"Nature"},{"key":"ref_104","doi-asserted-by":"crossref","unstructured":"Petersen, H.J., and Smith, A.M. (2013). The Role of the Innate Immune System in Granulomatous Disorders. Front. Immunol., 4.","DOI":"10.3389\/fimmu.2013.00120"},{"key":"ref_105","doi-asserted-by":"crossref","unstructured":"Azab, B., Rabab\u2019h, O., Aburizeg, D., Mohammad, H., Dardas, Z., Mustafa, L., Khasawneh, R.A., Awad, H., Hatmal, M.M., and Altamimi, E. (2022). Potential Composite Digenic Contribution of NPC1 and NOD2 Leading to Atypical Lethal Niemann-Pick Type C with Initial Crohn\u2019s Disease-like Presentation: Genotype-Phenotype Correlation Study. Genes, 13.","DOI":"10.3390\/genes13060973"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"11","DOI":"10.12688\/wellcomeopenres.16986.1","article-title":"Anti-TNF therapy for inflammatory bowel disease in patients with neurodegenerative Niemann-Pick disease Type C","volume":"7","author":"Williams","year":"2022","journal-title":"Wellcome Open Res."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"e225","DOI":"10.1097\/PG9.0000000000000225","article-title":"Dual Biologic Therapy in a Patient With Niemann-Pick Type C and Crohn Disease: A Case Report and Literature Review","volume":"3","author":"Hudson","year":"2022","journal-title":"JPGN Rep."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1172\/JCI9677","article-title":"Congenital Sucrase-Isomaltase Deficiency Arising from Cleavage and Secretion of a Mutant Form of the Enzyme","volume":"106","author":"Jacob","year":"2000","journal-title":"J. Clin. Investig."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1007\/s10545-012-9523-9","article-title":"Miglustat-induced intestinal carbohydrate malabsorption is due to the inhibition of \u03b1-glucosidases, but not \u03b2-galactosidases","volume":"35","author":"Amiri","year":"2012","journal-title":"J. Inherit. Metab. Dis."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1016\/S0960-9822(01)00446-8","article-title":"Apical Membrane Proteins Are Transported in Distinct Vesicular Carriers","volume":"11","author":"Jacob","year":"2001","journal-title":"Curr. Biol."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"10683","DOI":"10.1074\/jbc.M109357200","article-title":"Intestinal Dipeptidyl Peptidase IV Is Efficiently Sorted to the Apical Membrane through the Concerted Action of N- andO-Glycans as Well as Association with Lipid Microdomains","volume":"277","author":"Alfalah","year":"2002","journal-title":"J. Biol. Chem."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/8904_2015_454","article-title":"The Pathobiochemistry of Gastrointestinal Symptoms in a Patient with Niemann-Pick Type C Disease","volume":"Volume 25","author":"Morava","year":"2015","journal-title":"JIMD Reports, Volume 25"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1007\/s10545-014-9725-4","article-title":"Long Term Differential Consequences of Miglustat Therapy on Intestinal Disaccharidases","volume":"37","author":"Amiri","year":"2014","journal-title":"J. Inher. Metab. Dis."},{"key":"ref_114","unstructured":"Scriver, C.R., Beaudet, A.L., Sly, W.S., and Valle, D. (2001). The Mucopolysaccharidoses. The Metabolic and Molecular Bases of Inherited Disease, McGraw-Hill Co."},{"key":"ref_115","doi-asserted-by":"crossref","unstructured":"Gragnaniello, V., Gueraldi, D., Rubert, L., Manzoni, F., Cazzorla, C., Giuliani, A., Polo, G., Salviati, L., and Burlina, A. (2020). Report of Five Years of Experience in Neonatal Screening for Mucopolysaccharidosis Type I and Review of the Literature. Int. J. Neonatal Screen., 6.","DOI":"10.3390\/ijns6040085"},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1080\/10408363.2021.2021846","article-title":"Newborn Screening of Mucopolysaccharidosis Type I","volume":"59","author":"Burlina","year":"2022","journal-title":"Crit. Rev. Clin. Lab. Sci."},{"key":"ref_117","doi-asserted-by":"crossref","unstructured":"Thomas, S., Ramaswami, U., Cleary, M., Yaqub, M., and Raebel, E.M. (2021). Gastrointestinal Manifestations in Mucopolysaccharidosis Type III: Review of Death Certificates and the Literature. J. Clin. Med., 10.","DOI":"10.3390\/jcm10194445"},{"key":"ref_118","first-page":"100621","article-title":"Incidental Diagnosis of Mucopolysaccharidosis Type I in an Infant with Chronic Intestinal Pseudoobstruction by Exome Sequencing","volume":"24","author":"Cospain","year":"2020","journal-title":"Mol. Genet. Metab. Rep."},{"key":"ref_119","first-page":"2429","article-title":"A case of chronic intestinal pseudo-obstruction complicated by mucopolysaccharidosis I Scheie type","volume":"83","author":"Inuzuka","year":"1986","journal-title":"Nihon Shokakibyo Gakkai Zasshi."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1002\/jcp.21682","article-title":"Gastrointestinal Pathology in a Mouse Model of Mucopolysaccharidosis Type IIIA","volume":"219","author":"Roberts","year":"2009","journal-title":"J. Cell. Physiol."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/0887-8994(96)00083-5","article-title":"Sanfilippo syndrome type C: A clinicopathological autopsy study of a long-term survivor","volume":"14","author":"Kurihara","year":"1996","journal-title":"Pediatr. Neurol."},{"key":"ref_122","doi-asserted-by":"crossref","unstructured":"W\u0119grzyn, G., Kurlenda, J., Liberek, A., Tylki-Szyma\u0144ska, A., Czartoryska, B., Piotrowska, E., Jak\u00f3bkiewicz-Banecka, J., and W\u0119grzyn, A. (2005). Atypical Microbial Infections of Digestive Tract May Contribute to Diarrhea in Mucopolysaccharidosis Patients: A MPS I Case Study. BMC Pediatr., 5.","DOI":"10.1186\/1471-2431-5-9"},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"7037","DOI":"10.1073\/pnas.1704367114","article-title":"How Members of the Human Gut Microbiota Overcome the Sulfation Problem Posed by Glycosaminoglycans","volume":"114","author":"Cartmell","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1038\/s41467-020-14509-4","article-title":"Metabolism of Multiple Glycosaminoglycans by Bacteroides Thetaiotaomicron Is Orchestrated by a Versatile Core Genetic Locus","volume":"11","author":"Ndeh","year":"2020","journal-title":"Nat. Commun."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"2068367","DOI":"10.1080\/19490976.2022.2068367","article-title":"Utilization of Glycosaminoglycans by the Human Gut Microbiota: Participating Bacteria and Their Enzymatic Machineries","volume":"14","author":"Rawat","year":"2022","journal-title":"Gut Microbes"},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1038\/s41586-021-03967-5","article-title":"A single sulfatase is required to access colonic mucin by a gut bacterium","volume":"598","author":"Luis","year":"2021","journal-title":"Nature"},{"key":"ref_127","doi-asserted-by":"crossref","unstructured":"Barbero-Herranz, R., Garriga-Garc\u00eda, M., Moreno-Blanco, A., Palacios, E., Ruiz-Sala, P., Vicente-Santamar\u00eda, S., Stanescu, S., Belanger-Quintana, A., Pintos-Morell, G., and Arconada, B. (2024). The Role of the Gut Microbiota in Sanfilippo Syndrome\u2019s Physiopathology: An Approach in Two Affected Siblings. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25168856"},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"e20854","DOI":"10.1016\/j.heliyon.2023.e20854","article-title":"Serological Short-Chain Fatty Acid and Trimethylamine N-Oxide Microbial Metabolite Imbalances in Young Adults with Acute Myocardial Infarction","volume":"9","year":"2023","journal-title":"Heliyon"},{"key":"ref_129","doi-asserted-by":"crossref","unstructured":"Hu, S., Kuwabara, R., De Haan, B.J., Smink, A.M., and De Vos, P. (2020). Acetate and Butyrate Improve \u03b2-Cell Metabolism and Mitochondrial Respiration under Oxidative Stress. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21041542"},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/s41423-023-00987-1","article-title":"Complex regulatory effects of gut microbial short-chain fatty acids on immune tolerance and autoimmunity","volume":"20","author":"Kim","year":"2023","journal-title":"Cell Mol. Immunol."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1097\/MPG.0b013e31818a082a","article-title":"Chronic Diarrhea in Mucopolysaccharidosis IIIB","volume":"49","author":"Sibilio","year":"2009","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"ref_132","first-page":"E138","article-title":"Linfangiectasia intestinal en un paciente afectado de s\u00edndrome de Sanfilippo B","volume":"119","author":"Romero","year":"2021","journal-title":"Arch. Argent. Pediat"},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.cradex.2004.05.002","article-title":"Characteristic Imaging Findings in Wolman\u2019s Disease","volume":"59","author":"Low","year":"2004","journal-title":"Clin. Radiol. Extra."},{"key":"ref_134","first-page":"132","article-title":"Wolman\u2019s Disease: A Rare Cause of Infantile Cholestasis and Cirrhosis","volume":"11","author":"Menon","year":"2020","journal-title":"J. Pediatr. Genet."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.prp.2003.11.001","article-title":"Wolman Disease and Cholesteryl Ester Storage Disease Diagnosed by Histological and Ultrastructural Examination of Intestinal and Liver Biopsy","volume":"200","author":"Boldrini","year":"2004","journal-title":"Pathol. Res. Pract."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"31","DOI":"10.37549\/AR2369","article-title":"Wolman Disease","volume":"46","author":"Dao","year":"2017","journal-title":"Appl. Radiol."},{"key":"ref_137","doi-asserted-by":"crossref","unstructured":"de Las Heras, J., Almohalla, C., Blasco-Alonso, J., Bourbon, M., Couce, M.L., de Castro L\u00f3pez, M.J., Garc\u00eda Jim\u00e9nez, M.C., Gil Ortega, D., Gonz\u00e1lez-Di\u00e9guez, L., and Meavilla, S. (2024). Practical Recommendations for the Diagnosis and Management of Lysosomal Acid Lipase Deficiency with a Focus on Wolman Disease. Nutrients, 16.","DOI":"10.3390\/nu16244309"},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/j.gie.2021.12.004","article-title":"A Rare Case of Lysosomal Acid Lipase Deficiency Diagnosed by Endoscopy","volume":"95","author":"Torres","year":"2022","journal-title":"Gastrointest. Endosc."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1007\/BF02013008","article-title":"Wolman\u2019s disease: Ultrasonographic and computed tomographic findings","volume":"22","author":"Ozmen","year":"1992","journal-title":"Pediatr. Radiol."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"2364","DOI":"10.3748\/wjg.v11.i15.2364","article-title":"Severe Chronic Diarrhea and Weight Loss in Cholesteryl Ester Storage Disease: A Case Report","volume":"11","author":"Drebber","year":"2005","journal-title":"World J. Gastroenterol."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1007\/s00247-003-0873-1","article-title":"Ultrasound Appearance of Bowel Wall in Wolman\u2019s Disease","volume":"33","author":"Nchimi","year":"2003","journal-title":"Pediatr. Radiol."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"e5","DOI":"10.1053\/j.gastro.2021.02.032","article-title":"Gastrointestinal Manifestations of a Rare Lipid Storage Disorder","volume":"161","author":"Yilmaz","year":"2021","journal-title":"Gastroenterology"},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"2857","DOI":"10.1016\/j.radcr.2021.06.084","article-title":"CT Features of Wolman Disease (Lysosomal Acid Lipase Enzyme Deficiency)\u2014A Case Report","volume":"16","author":"Foladi","year":"2021","journal-title":"Radiol. Case Rep."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"E105","DOI":"10.1097\/MPG.0000000000002030","article-title":"Endoscopic Findings in Lysosomal Acid Lipase Deficiency","volume":"68","author":"Kyosen","year":"2019","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.jdcr.2021.12.014","article-title":"Novel Association of Metastatic Crohn\u2019s Disease and Wolman Disease","volume":"20","author":"AlAsmari","year":"2022","journal-title":"JAAD Case Rep."}],"container-title":["Metabolites"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2218-1989\/15\/6\/361\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T17:42:51Z","timestamp":1760031771000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2218-1989\/15\/6\/361"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,29]]},"references-count":145,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2025,6]]}},"alternative-id":["metabo15060361"],"URL":"https:\/\/doi.org\/10.3390\/metabo15060361","relation":{},"ISSN":["2218-1989"],"issn-type":[{"value":"2218-1989","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,29]]}}}